or Try an Advanced Search...

    Technical Analysis for CLSD - Clearside Biomedical, Inc.

    Grade Last Price % Change Price Change
    F 1.05 1.94% 0.02
    CLSD closed up 1.94 percent on Wednesday, November 20, 2024, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CLSD trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    Jack-in-the-Box Bearish Bearish Swing Setup 2.94%
    Inside Day Range Contraction 2.94%
    MACD Bearish Signal Line Cross Bearish 6.06%
    Older End-of-Day Signals for CLSD ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 17 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    Up 2% about 20 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Up 1% about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CLSD Chart by TradingView
    Basic chart:

    Profile

    Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Drug Therapies Wet Age Related Macular Degeneration Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion

    Is CLSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
    Nov 15 Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
    Nov 13 Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...
    Nov 13 Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript
    Nov 12 Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M
    Nov 12 Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 11 Clearside Biomedical Q3 2024 Earnings Preview
    Nov 10 Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years
    See more CLSD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.12
    52 Week Low 0.92
    Average Volume 856,523
    200-Day Moving Average 1.26
    50-Day Moving Average 1.18
    20-Day Moving Average 1.06
    10-Day Moving Average 1.07
    Average True Range 0.08
    RSI (14) 45.05
    ADX 10.83
    +DI 17.93
    -DI 21.68
    Chandelier Exit (Long, 3 ATRs) 1.09
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.14
    Lower Bollinger Band 0.98
    Percent B (%b) 0.41
    BandWidth 14.78
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram 0.0001
    Fundamentals Value
    Market Cap 66.79 Million
    Num Shares 63.6 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -1.72
    Price-to-Sales 40.85
    Price-to-Book 3.93
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.11
    Resistance 3 (R3) 1.11 1.09 1.10
    Resistance 2 (R2) 1.09 1.07 1.09 1.10
    Resistance 1 (R1) 1.07 1.07 1.08 1.07 1.09
    Pivot Point 1.05 1.05 1.06 1.05 1.05
    Support 1 (S1) 1.03 1.03 1.04 1.03 1.01
    Support 2 (S2) 1.01 1.03 1.01 1.00
    Support 3 (S3) 0.99 1.01 1.00
    Support 4 (S4) 0.99